Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/TRANSPHORM INC/ 10-K

Annual Report · 10-K

TRANSPHORM INC

Annual Report

Filed Sep 28, 2018Accepted Sep 28, 2018, 10:54 AM EDTCIK 1715768Accession 0001213900-18-013174
View company →Permanent SEC source ↗
Share

Company context

Historical securities (1)
TGANNASDAQ · EQUITY · Historical · closed Jun 20, 2024

Recent company filings

  1. 15-12G filingJul 1, 2024
  2. EFFECT filingJun 20, 2024
  3. EFFECT filingJun 20, 2024
  4. EFFECT filingJun 20, 2024
  5. EFFECT filingJun 20, 2024

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗